Elizabeth Holmes, the disgraced ex-CEO of the now-defunct Theranos, continues to be in the news. In the past several weeks, news reports indicate that she gave birth to a child, but whether it is a boy or a girl has not been reported. Also in recent weeks, attorneys have been in court arguing about unsealing certain court records. Included in the sealed records is the psychological evaluation of Holmes.Ā
MORE ON: Holmes and Theranos
In July, Wall Street Journal reporter John Carreyrou, who wrote the stories that brought down Holmes and Theranos, told CNBC News, āA large part of her defense now looks to be blaming Sunny [Balwani, who was COO at Theranos, and Holmesā boyfriend] and basically saying to the jury that Sunny held her in his psychological grip. Her defense plans on making the case that Balwani was the older boyfriendā19 years olderāwho was really the puppeteer here, and she was the puppet. And obviously theyāre going to trot out a psychologist to help make that case.ā Holmes and Balwani face multiple federal criminal charges of wire fraud and conspiracy to commit fraud for her actions during her leadership of Theranos. Government prosecutors say she deceived investors, doctors, and patients about the performance of Theranosā lab testing capabilities.
RICHEST WOMAN IN HEALTHCARE
In July, Forbes published a list of the richest women in healthcare. Topping the list was Judith Faulkner, CEO of Epic Systems. Forbes estimated her net worth at $6.5 billion.
TRANSITIONS
ā¢ David Hickey joined Illumina of San Diego as Vice President of Regional Marketing. Formerly he served at Pacific Biosciences, Affymetrix, Ingenuity Systems, and Incyte Genomics.Ā
ā¢ Personal Genome Diagnostics of Baltimore announced that Jamie Platt, PhD, is its new Chief Operations Officer. She previously served at BRIDGenomics, Inivata, Molecular Pathology Laboratory Network (MPLN), BasePrime Gx, and Quest Diagnostics.
ā¢ Maggie Rougier-Chapman was announced as the Senior Vice President of Marketing and Commercial Strategy at Personal Genome Diagnostics. Her prior positions were at Footprint BioAdvisors, Invitae, ArcherDx, Bionano Genomics, and Agilent Technologies.
ā¢ Charudutt Shah is the new Chief Business Officer and board member at Genomtec of WrocÅaw, Poland. Prior positions were with BioFire, Spartan Bioscience, Luminex, and Life Technologies.
